Neola Medical AB — Investor Relations & Filings

Neola Medical AB develops medical technology for neonatal intensive care. The company's primary product is Neola®, the Neonatal Lung Analyzer, a device designed for continuous, non-invasive monitoring of the lungs of preterm infants. The system uses a patented technology called Gas in Scattering Media Absorption Spectroscopy (GASMAS), which employs safe infrared light to provide real-time data and alerts for critical lung complications. The objective is to enable instant detection of adverse events, allowing for earlier clinical intervention to improve patient outcomes and establish a new standard of care for vulnerable newborns. The device is currently in the clinical study phase to support future market authorization.